
Recovery
BPC-157
10mg
$48.75$65.00



Front
Recovery
$48.75$65.00
Strength · 10mg
ARA-290 is a synthetic peptide derived from the erythropoietin molecule, researched for its selective signaling through the innate-repair receptor.
Research Notice
For laboratory research use only. Not for human consumption.
The Dossier
ARA-290, also known as cibinetide, is a synthetic eleven-amino-acid peptide modeled on the helix-B surface domain of erythropoietin. Unlike full-length erythropoietin, it is non-hematopoietic — engineered to isolate the molecule's tissue-protective signaling from its blood-cell activity.
Research interest centers on its selective engagement of the innate repair receptor, a complex expressed by tissues under stress rather than at rest. It is offered strictly as a laboratory reference compound.
Research Focus
Mechanism
ARA-290 selectively binds the innate repair receptor — a heterocomplex of the erythropoietin receptor and the CD131 beta-common receptor — which is upregulated locally in response to injury, hypoxia, or metabolic stress rather than in healthy tissue. It does not engage the receptor form responsible for red-blood-cell production.
Receptor engagement has been characterized as initiating JAK2-mediated signaling across STAT, PI3K/Akt, and MAPK pathways, alongside attenuation of NF-κB-driven inflammatory signaling.
Molecular Profile
Storage & Handling
Store the lyophilized peptide at −20°C, protected from light; refrigerated storage is stable over the medium term. Reconstituted solutions are held refrigerated at 2–8°C and used within weeks; avoid repeated freeze-thaw.
References
✦Every vial ships with third-party HPLC verification; certificates of analysis are available on request.
Continue Exploring